Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Vtama® (tapinarof) – New indication

December 12, 2024 - The FDA approved Dermavant Sciences’ Vtama (tapinarof), for the topical treatment of atopic dermatitis in adults and pediatric patients 2 years of age and older.

Download PDF

Rx navigation